Join
Live feed
·
INSIDERFilingvia Quantisnow
OKYO Pharma Limited logo

CHIEF EXECUTIVE OFFICER Dempsey Robert John was granted 15,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
OKYO· OKYO Pharma Limited
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OKYO (OKYO Pharma Limited) and more on Quantisnow.